The Oswaldo Cruz Foundation (Fiocruz) collaborative and open access web space at TGHN aims to strengthen networks and improve capacities for public health research regionally and globally, by providing a vibrant virtual environment where professionals, students and researchers can share experiences, knowledge, method tools and resources.
Fiocruz is the most prominent Institution of Science and Technology in Health in Latin America. Bound to the Ministry of Health, its mission is to produce, disseminate and share knowledge and technologies, aiming at strengthening and consolidating the Unified Health System (SUS, acronym in Portuguese for the Brazilian public health system) and the promotion of health and quality of life for the population.
Abstract Data is becoming ever more critical and valuable for both scientists and health authorities searching for answers to the COVID-19 crisis. Due to difficulties in diagnosing this infection in ...
The 2015 to 2017 outbreak of Zika generated global attention on the risk of a spectrum of neurological disorders posed to women and their unborn children—including, but not limited to ...
Abstract Background Science studies have been a field of research for different knowledge areas, and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination ...
On March 11th, 2020, the World Health Organization (WHO) declared COVID-19 (the disease caused by the novel coronavirus SARS-CoV-2) a pandemic. As of this article's writing, more than 1 ...
The emergence of Zika virus in 2015 challenged conventional ideas of mosquito-borne diseases, tested the resilience of health systems and embedded itself within local sociocultural worlds, with major implications for ...
The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary ...
Fiocruz 120 years anniversary
Watch now LIVE
Watch the webinar, in Portuguese
Vulnerabilidades, impactos e o enfrentamento à COVID-19 no contexto dos povos indígenas
Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more
28/04/2020 Ricardo Valverde Photo: © Wilfred Paulse A group of researchers of the Oswaldo Cruz Foundation (Fiocruz) and of the Getulio Vargas Foundation (FGV) has just released a report on the risk of Covid-19 dissemination among indigenous populations, due to ... Read more
A Fiocruz research has observed that the drug Atazanavir, used against HIV, was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs, and therefore to the worsening ... Read more
28/04/2020 Fiocruz The Oswaldo Cruz Foundation (Fiocruz) will be producing 11 million tests for the Ministry of Health (MS) by September. The Foundation began supplying the tests on March 4. The goal of the first agreement was to produce 25,000 ... Read more
20/05/2020 COC/Fiocruz The animation Carlos Chagas, which features the paths taken by the scientist until the discovery of Chagas disease, has just got a version in English. Available on the Internet, the episode is part of the series, Ciência em ... Read more
28/04/2020 Icict/Fiocruz The number of deaths caused by Covid-19 has doubled every 5 days in Brazil, on average. In the United States and in Ecuador, countries with high dissemination rates, the interval necessary for this duplication is an average of ... Read more
Follow the Fiocruz response and Brazilian actions and numbers regarding the COVID-19 pandemic.
Go to page
